While CCNT1 is not associated with survival in breast cancer as a whole, low expression is associated with longer survival in luminal A cancer (HR 1.98, p = 0.0155); similarly, low CLOCK expression was associated with increased survival in all breast cancer subtypes as well as the luminal A subtype. This evidence concerns the gene CLOCK and breast carcinoma.